[Cardiovascular biomarkers in clinical practice of sleep apnea]

Dursun Dursunoğlu1, Neşe Dursunoğlu

  • 1Department of Cardiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey. dursundursunoglu@yahoo.com

Tuberkuloz Ve Toraks
|January 12, 2012
PubMed

Insights

Obstructive sleep apnea syndrome (OSAS) significantly elevates cardiovascular risks, including heart failure and stroke. Reviewing cardiovascular biomarkers aids in early diagnosis and prognosis for OSAS patients.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Biomarker Research

Context:

  • Obstructive sleep apnea syndrome (OSAS) is linked to severe cardiovascular complications.
  • These complications include coronary artery disease, heart failure, hypertension, and stroke, increasing OSAS morbidity and mortality.
  • Heart failure patients may also experience sleep-related breathing disorders like Cheyne-Stokes respiration and various apneas.

Purpose:

  • To review the role of cardiovascular biomarkers in the early diagnosis, treatment, and prognosis of OSAS.
  • To explore the clinical significance of specific biomarkers in the context of OSAS-related cardiovascular pathology.

Summary:

  • OSAS contributes to a range of cardiovascular issues, including ventricular dysfunction, heart failure, and arrhythmias.
  • Hypoxemia-induced sympathetic overactivity and endothelial dysfunction are key mechanisms.
  • Key biomarkers discussed include C-reactive protein (CRP), TNF-α, interleukins, adiponectin, hFABP, and BNP.

Impact:

  • Highlights the importance of cardiovascular biomarkers for managing OSAS patients.
  • Provides insights into the pathophysiological links between sleep apnea and heart disease.
  • Aids clinicians in risk stratification and therapeutic decision-making for OSAS-related cardiovascular conditions.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...